Research
Size:
Share:
Search studies by: All,
Active,
Completed

RUBY – Sponsored by Regeneron Pharmaceuticals, Inc.

Active Study | Duration: 36 weeks

RUBY REGN910-3 is a multi-center, prospective, and randomized Phase II clinical trial for the treatment of Diabetic Macular Edema (DME). It compares the efficacy of... View study

ALLEGRO PVD – Sponsored by Allegro Ophthalmics, LLC

Completed Study | Duration: 90 days

ALLEGRO PVD is a multi center, prospective, randomized, and placebo-controlled Phase II clinical trial for the induction of Posterior Vitreous Detachment (PVD). There... View study

ALLEGRO DME – Sponsored by Allegro Ophthalmic, LLC

Completed Study | Duration: Six months

ALLEGRO DME was a multi center, prospective, and randomized Phase II clinical trial for the treatment of Diabetic Macular Edema (DME). It compared the efficacy of... View study

Intravitreal triamcinolone acetonide injections and Laser Photocoagulation in the treatment of Diabetic Macular Edema. View study

FAME - Sponsored by Alimera Sciences

Completed Study | Duration: 36 months

Iluvien® is an extended release intravitreal insert developed for the treatment of Diabetic Macular Edema. During the trial, Iluvien® demonstrated a significant effect... View study

Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) in combination with laser versus laser alone in the treatment of Diabetic Macular Edema. View study